These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26318763)

  • 1. Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy.
    Iturriaga-Vásquez P; Alzate-Morales J; Bermudez I; Varas R; Reyes-Parada M
    Pharmacol Res; 2015 Nov; 101():9-17. PubMed ID: 26318763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
    Reyes-Parada M; Iturriaga-Vasquez P
    Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
    Pandya AA
    Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of native nicotinic receptor subtypes in mammalian brain.
    Zoli M; Pistillo F; Gotti C
    Neuropharmacology; 2015 Sep; 96(Pt B):302-11. PubMed ID: 25460185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
    Nirogi R; Goura V; Abraham R; Jayarajan P
    Eur J Pharmacol; 2013 Jul; 712(1-3):22-9. PubMed ID: 23660369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
    Grupe M; Grunnet M; Bastlund JF; Jensen AA
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in understanding the structure of nicotinic acetylcholine receptors.
    Zouridakis M; Zisimopoulou P; Poulas K; Tzartos SJ
    IUBMB Life; 2009 Apr; 61(4):407-23. PubMed ID: 19319967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.
    Molgó J; Aráoz R; Benoit E; Iorga BI
    Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment.
    Bertrand D; Bertrand S; Cassar S; Gubbins E; Li J; Gopalakrishnan M
    Mol Pharmacol; 2008 Nov; 74(5):1407-16. PubMed ID: 18678621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of nicotinic acetylcholine receptors.
    Bertrand D; Gopalakrishnan M
    Biochem Pharmacol; 2007 Oct; 74(8):1155-63. PubMed ID: 17707779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic acetylcholine receptors: from structure to brain function.
    Hogg RC; Raggenbass M; Bertrand D
    Rev Physiol Biochem Pharmacol; 2003; 147():1-46. PubMed ID: 12783266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulators of α4β2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery.
    Mantione E; Micheloni S; Alcaino C; New K; Mazzaferro S; Bermudez I
    Future Med Chem; 2012 Nov; 4(17):2217-30. PubMed ID: 23190109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
    Schrattenholz A; Pereira EF; Roth U; Weber KH; Albuquerque EX; Maelicke A
    Mol Pharmacol; 1996 Jan; 49(1):1-6. PubMed ID: 8569694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications.
    Romanelli MN; Gualtieri F
    Med Res Rev; 2003 Jul; 23(4):393-426. PubMed ID: 12710018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight in nAChR subtype selectivity from AChBP crystal structures.
    Rucktooa P; Smit AB; Sixma TK
    Biochem Pharmacol; 2009 Oct; 78(7):777-87. PubMed ID: 19576182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Studies of Nicotinic Acetylcholine Receptors: Using Acetylcholine-Binding Protein as a Structural Surrogate.
    Shahsavar A; Gajhede M; Kastrup JS; Balle T
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):399-407. PubMed ID: 26572235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.